Programmable Viruses

We are developing a new kind of programmable viral vector that can be targeted to precisely defined cell types throughout the body. We are testing our vectors for use in gene therapy and cancer therapy, with greater efficacy and reduced side-effects compared to existing solutions.

Category

Viral Vectors

 

People

Daniele Cervettini

Bhuvana Sudarshan

 

Collaborators


Milestones

2021: Project launched
2022: Grant obtained ($2,000,000 USD)

 

Papers





If you’re interested in this project, contact us.

Previous
Previous

Molecularly-Annotated Connectome

Next
Next

RNA Timestamps